Andy Hurley Named Agenus Chief Commercial Officer

by NASDAQ Market News February 9, 2021

NASDAQ Market News
Click here to email author

FDA approves Libtayo® (Cemiplimab-rwlc) as first immunotherapy indicated for patients with advanced basal cell carcinoma

Revive Therapeutics Receives Receipt for Final Short-Form Prospectus for Previously Announced $20 Million Bought Deal Public Offering

Ads